Quantitative Proteomics of Transporter Expression in Brain Capillary Endothelial Cells Isolated from P-Glycoprotein (P-gp), Breast Cancer Resistance Protein (Bcrp), and P-gp/Bcrp Knockout Mice

被引:102
作者
Agarwal, Sagar [1 ]
Uchida, Yasuo [2 ]
Mittapalli, Rajendar K. [1 ]
Sane, Ramola [1 ]
Terasaki, Tetsuya [2 ]
Elmquist, William F. [1 ]
机构
[1] Univ Minnesota, Dept Pharmaceut, Brain Barriers Res Ctr, Minneapolis, MN 55455 USA
[2] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan
基金
美国国家卫生研究院; 日本科学技术振兴机构;
关键词
CENTRAL-NERVOUS-SYSTEM; BARRIER; PENETRATION; EFFLUX; MITOXANTRONE; INSIGHTS; FAMILY; ABCG2;
D O I
10.1124/dmd.112.044719
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to quantitatively examine the protein expression of relevant transporters and other proteins in the brain capillary endothelial cells isolated from wild-type mice and P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice. After the isolation of brain capillary endothelial cells, a highly sensitive liquid chromatography-tandem mass spectrometry method with multiple reaction monitoring was used to determine the quantitative expression of membrane transporters at the blood-brain barrier (BBB) of the various mouse genotypes. Quantitative expression of 29 protein molecules, including 12 ATP-binding cassette transporters, 10 solute carrier transporters, five receptors, and two housekeeping proteins, was examined by quantitative proteomics in the four mouse genotypes. There was no significant difference in the expression of P-gp between the wild-type and Bcrp1(-/-) mice. Likewise, Bcrp expression was not significantly different between the wild-type and Mdr1a/b(-/-) mice. There was no significant difference in the expression of any of the measured proteins in the brain capillary endothelial cells across the genotypes, except for the lack of expression of the corresponding protein in the mice that had a genetic deletion of P-gp or Bcrp. In conclusion, using a quantitative proteomic approach, we have shown that there are no changes in the expression of several relevant transporters in brain capillary endothelial cells isolated from single and combination knockout mice. These data suggest that the mechanism behind the functional compensation between P-gp and Bcrp at the BBB is not related to compensatory changes in transporter expression.
引用
收藏
页码:1164 / 1169
页数:6
相关论文
共 22 条
[1]   Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up [J].
Agarwal, Sagar ;
Hartz, Anika M. S. ;
Elmquist, William F. ;
Bauer, Bjoern .
CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (26) :2793-2802
[2]   The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain [J].
Agarwal, Sagar ;
Sane, Ramola ;
Ohlfest, John R. ;
Elmquist, William F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (01) :223-233
[3]   Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux [J].
Agarwal, Sagar ;
Sane, Ramola ;
Gallardo, Jose L. ;
Ohlfest, John R. ;
Elmquist, William F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01) :147-155
[4]   P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib [J].
Chen, Ying ;
Agarwal, Sagar ;
Shaik, Naveed M. ;
Chen, Cliff ;
Yang, Zheng ;
Elmquist, William F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03) :956-963
[5]   Expression, up-regulation, and transport activity of the multidrug-resistance protein ABCG2 at the mouse blood-brain barrier [J].
Cisternino, S ;
Mercier, C ;
Bourasset, F ;
Roux, F ;
Scherrmann, JM .
CANCER RESEARCH, 2004, 64 (09) :3296-3301
[6]   Multidrug resistance-associated proteins: Expression and function in the central nervous system [J].
Dallas, Shannon ;
Miller, David S. ;
Bendayan, Reina .
PHARMACOLOGICAL REVIEWS, 2006, 58 (02) :140-161
[7]   P-glycoprotein and breast cancer resistance protein: Two dominant transporters working together in limiting the brain penetration of topotecan [J].
de Vries, Nienke A. ;
Zhao, Jin ;
Kroon, Emily ;
Buckle, Tessa ;
Beijnen, Jos H. ;
van Tellingen, Olaf .
CLINICAL CANCER RESEARCH, 2007, 13 (21) :6440-6449
[8]  
Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]
[9]   17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity [J].
Hartz, Anika M. S. ;
Mahringer, Anne ;
Miller, David S. ;
Bauer, Bjoern .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (10) :1742-1755
[10]   Quantitative atlas of membrane transporter proteins:: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria [J].
Kamiie, Junichi ;
Ohtsuki, Sumio ;
Iwase, Ryo ;
Unine, Ken ;
Katsukura, Yuki ;
Yanai, Kazunari ;
Sekine, Yumi ;
Uchida, Yasuo ;
Ito, Shingo ;
Terasaki, Tetsuya .
PHARMACEUTICAL RESEARCH, 2008, 25 (06) :1469-1483